Chile - agreement IPILIMUMAB INJECTABLE SOLUTION 400 mg/50 mL - IPILIMUMAB INJECTAB SOLUTION 50 mg/10 mL

For more information and to make a bid you will need to go to the third party website.

Details

Provided by

Opportunity closing date

01 June 2020

Opportunity publication date

10 May 2020

Value of contract

to be confirmed

Your guide to exporting

Report opportunity

supplying medicines to hggb patients

The deadline to apply for this opportunity has passed.
Visit the opportunities page to find another.